NCT07907328
FUS Neuromodulation for Binge Eating Disorder
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 1 with changes below, 1 re-verified with no change.
- Study First Submitted
Endpoints
Primary
Occurrence of Treatment Emergent Adverse Events
Timeframe: baseline compared to 4 and 12 weeks after study procedure
Secondary (3)
Change in Food craving
Change in Eating behavior
change in eating Behavior
Arms and interventions
FUS NeuromodulationExperimental
Devices: LIFU Neuromodulation
Sites
1 site in 1 country
- West Virginia University: Rockefeller Neuroscience InstituteMorgantown, West Virginia, United States